Dihydroxyphenylglycol in pheochromocytoma: Its diagnostic use for norepinephrine dominant tumor

Journal of Urology

Volumn 155, Issue 1, 1996, Pages 14-18

  Nakada, Teruhiro ^a   Sasagawa, Isoji ^a   Kubota, Yoko ^a   Suzuki, Hitoshi ^a   Ishigooka, Manabu ^a   Watanabe, Morihiro ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Adrenal medulla; Epinephrine; Norepinephrine; Pheochromocytoma

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ADRENALIN; CATECHOL METHYLTRANSFERASE; NORADRENALIN;

ADRENAL MEDULLA; ADRENALECTOMY; ADRENALIN URINE LEVEL; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; NEPHRECTOMY; NORADRENALIN URINE LEVEL; PHEOCHROMOCYTOMA; PRIORITY JOURNAL;

ADRENAL GLAND NEOPLASMS; ADRENAL MEDULLA; CARCINOMA, RENAL CELL; COMPARATIVE STUDY; EPINEPHRINE; FEMALE; HUMAN; KIDNEY NEOPLASMS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGE; NOREPINEPHRINE; PHEOCHROMOCYTOMA; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL;

EID: 0029655331     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66526-1     Document Type: Article

References (19)

1. Goldstein, D. S., Eisenhofer, G., Stull, R., Folio, C. J., Keiser, H. R. and Kopin, I. J.: Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J. Clin. Invest., 81: 213, 1988.
2. Lenders, J. W., Willemsen, J. J., Beissel, T., Kloppenborg, P. W., Thien, T. and Benraad, T. J.: Value of the plasma norepinephrine/3,4-dihydroxyphenylglycol ratio for the diagnosis of pheochromocytoma. Amer. J. Med., 92: 147, 1992.
3. Brown, M. J.: Simultaneous assay of noradrenaline and its deaminated metabolite, dihydroxyphenylglycol, in plasma: a simplified approach to the exclusion of phaeochromocytoma in patients with borderline elevation of plasma noradrenaline concentration. Eur. J. Clin. Invest., 14: 67, 1984.
4. Smythe, G. A., Edwards, G., Graham, P. and Lazarus, L.: Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine. Clin. Chem., 38: 486, 1992.
5. Duncan, M. W., Compton, P., Lazarus, L. and Smythe, G. A.: Measurement of norepinephrine and 3,4-dihydroxyphenylglycol in urine and plasma for the diagnosis of pheochromocytoma. New Engl. J. Med., 319: 136, 1988.
6. Wagner, J., Vitali, P., Palfreyman, M. G., Zraika, M. and Huot, S.: Simultaneous determination of 3,4-dihydroxyphenylamine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-methoxyphenylanie, norepinephrine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5-hydroxyindoleacetic acid in rat cerebrospinal fluid and brain by high-performance liquid chromatography with electrochemical detection. Neurochemistry, 38: 1241, 1982.
7. Nakada, T., Furuta, H. and Katayama, T.: Catecholamine metabolism in pheochromocytoma and normal adrenal medullae. J. Urol., 140: 1348, 1988.
8. Nakada, T., Sasagawa, I., Furuta, H., Katayama, T. and Shimazaki, J.: Age-related differences in norepinephrine and non-collagenous protein in human vas deferens. J. Urol., 141: 998, 1989.
9. Yamaguchi, T. and Nakada, T.: Catecholamine metabolism in the vas deferens and the adrenal gland with special reference to the central catecholamine-depleted state. Experientia, 48: 667, 1992.
10. Hoffmann, J. J., Willemsen, J. J., Thien, T. and Benraad, T. J.: Radioenzymatic assay of plasma adrenaline and noradrenaline: evidence for a catechol-O-methyltransferase (COMT) inhibiting factor associated with essential hypertension. Clin. Chim. Acta, 125: 319, 1982.
11. Hoffmann, J. J., Willemsen, J. J., Lenders, J. W. and Benraad, T. J.: Reduced imprecision of the radioenzymatic assay of plasma catecholamines by improving the stability of the internal standards. Clin. Chim. Acta, 156: 221, 1986.
12. DeQuattro, V. and Campese, V. M.: Functional components of the sympathetic nervous systems: regulation of organic systems. In: Endocrinology. Edited by L. J. DeGroot, G. F. Cahill, Jr., W. D. Odell, L. Martini, J. T. Potts, Jr., D. H. Nelson, E. Steinberger and A. I. Winegrad. New York: Grune & Stratton, Inc., vol. 2. chapt. 101, p. 1261-1278, 1979.
13. Hörtnagl, H., Magometschnigg, D., Lochs, H. and Druml, W.: A paroxysmally secreting phaeochromocytoma: biochemical and clinical aspects. Klin. Wochenschr., 61: 601, 1983.
14. Plouin, P. F., Duclos, J. M., Menard, J., Comoy, E., Bohoun, C. and Alexandre, J. M.: Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. Brit. Med. J., 282: 853, 1981.
15. Bravo, E. L.: Pheochromocytoma: new concepts and future trends. Kidney Int., 40: 544, 1991.
16. Izzo, J. L., Jr., Thompson, D. A. and Horwitz, D.: Plasma dihydroxyphenylglycol (DHPG) in the in vivo assessment of human neuronal norepinephrine metabolism. Life Sci., 37: 1033, 1985.
17. Eisenhofer, G., Esler, M. D., Cox, H. S., Meredith, I. T., Jennings, G. L., Brush, J. E., Jr. and Goldstein, D. S.: Differences in the neuronal removal of circulating epinephrine and norepinephrine. J. Clin. Endocr. Metab., 70: 1710, 1990.
18. Goldstein, D. S., Zimlichman, R., Stull, R., Folio, J., Levinson, P. D., Keiser, H. R. and Kopin, I. J.: Measurement of regional neuronal removal of norepinephrine in man. J. Clin. Invest., 76: 15, 1985.
19. Esler, M., Jackman, G., Leonard, P., Skews, H., Bobik, A. and Korner, P.: Effect of norepinephrine uptake blockers on norepinephrine kinetics. Clin. Pharmacol. Ther., 29: 12, 1981.